We previously reported that the Forkhead family transcription factor gene FOXC1, which is a critical regulator of normal mesenchymal and mesodermal differentiation, is highly expressed in around 20% of cases of AML, but not expressed in normal hematopoietic lineages (Somerville et al., 2015). This evidence concerns the gene FOXC1 and acute myeloid leukemia.